12 stories tagged with #crispr, in publish-time order across the WeSearch catalog. Tag pages update as new stories ingest.
⌘ RSS feed for this tag → or search "Crispr"
CRISPR makes prostate cancer vulnerable to immunotherapy
Scientists used CRISPR to make prostate cancer cells easier for the immune system to detect and destroy. The experimental treatment dramatically improved the effects of immunothera…
CRISPR Gene Editing Makes Stem Cells ‘Invisible’ to Immune System
UCSF scientists have used the CRISPR-Cas9 gene-editing system to create the first pluripotent stem cells that are functionally “invisible” to the immune system.…
U.S. IPO Weekly Recap: CRISPR Biotech Pops 44% As More Names Join The IPO Pipeline
Two sizable IPOs and one direct listing are currently scheduled in the week ahead, although some smaller deals may also join the calendar throughout the week. Read more here.…
Crispr Therapeutics: A Catalyst-Rich 12 Months Ahead
CRISPR Therapeutics offers a diversified gene-editing pipeline, with CASGEVY as its lead asset and multiple upcoming catalysts. See why I rate CRSP stock a Buy.…
STAT+: Next-gen CRISPR tools improve editing accuracy in embryos, but also stoke ethical concerns
The use of genome editing in early embryos has pulled back the curtain on the role of one of the key genes that orchestrates the first stages of human development,……
CRISPR Therapeutics AG (CRSP) Presents at Jefferies Global Healthcare Conference 2026 Transcript
CRISPR Therapeutics AG (CRSP) Jefferies Global Healthcare Conference 2026 June 3, 2026 9:55 AM EDTCompany ParticipantsSamarth Kulkarni - CEO &...…
CRISPR Therapeutics Stock Is Absurdly Cheap -- Here's Why Analysts See 437% Upside Potential
Citizens reiterates CRISPR Therapeutics stock rating on gene editing prospects
CRISPR Therapeutics’ SWOT analysis: gene therapy stock faces competitive pressures
These Are The Upcoming Catalysts For Crispr Therapeutics Stock
Crispr Therapeutics AG is a Buy: Casgevy adoption is slow, but Vertex partnership, $1.65B net cash, and 2026 catalysts support upside. Click for this CRSP update.…
Scientists find ‘holy grail’ of genes that could regrow human limbs
It sounds like science fiction, but scientists may have just taken a giant step toward a future where amputees regrow real limbs.…
China’s thalassaemia jab raises hope for common inherited blood disorder
Original therapy integrating stem cell tech and gene editing could treat a blood disorder with 350 million carriers worldwide.…